Bachem Holding AGBCHMF 96 Return-on-Tangible-Asset is 10.04% as of Dec. 2025, which is 22% above its 10-year median of 8.22. GuruFocus rates BCHMF with a GF Score™ of 96/100 and a GF Value™ of $98.06 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 1,412 Biotechnology companies, Bachem Holding AG ranks better than 90.08% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Bachem Holding AG's annualizedNet Income for the quarter that ended in Dec. 2025 was $247.7 Mil. Bachem Holding AG's average total tangible assets for the quarter that ended in Dec. 2025 was $2,466.3 Mil. Therefore, Bachem Holding AG's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 10.04%.
The historical rank and industry rank for Bachem Holding AG's Return-on-Tangible-Asset or its related term are showing as below:
BCHMF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.74 Med: 8.22 Max: 11.73
Current: 7.6
During the past 13 years, Bachem Holding AG's highest Return-on-Tangible-Asset was 11.73%. The lowest was 6.74%. And the median was 8.22%.
BCHMF's Return-on-Tangible-Asset is ranked better than 90.08% of 1412
companies
in the Biotechnology industry
Industry Median: -35.475
vs BCHMF: 7.60
Bachem Holding AG (OTCPK:BCHMF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Bachem Holding AG Return-on-Tangible-Asset Related Terms
Bachem Holding AG Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Bachem Holding AG's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BCHMF vs VRTX, REGN, ALNY: Return-on-Tangible-Asset Comparison
For the Biotechnology subindustry, Bachem Holding AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bachem Holding AG Return-on-Tangible-Asset vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bachem Holding AG's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Bachem Holding AG's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 10.04% mean?
Bachem Holding AG (BCHMF) has a Return-on-Tangible-Asset of 10.04% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Bachem Holding AG and its competitors. This is 22% above median its historical median of 8.22. Over the past decade, Bachem Holding AG's Return-on-Tangible-Asset has ranged from 6.74 to 11.73. According to the industry distribution chart, Bachem Holding AG ranks #140 out of 1412 companies in the Biotechnology industry, placing it in the top 9.9%.
Is Bachem Holding AG's Return-on-Tangible-Asset too high?
Bachem Holding AG's current Return-on-Tangible-Asset of 10.04% is 22% above median its 10-year median of 8.22. Over the past 10 years, this metric has ranged from a low of 6.74 to a high of 11.73. Based on the distribution chart, Bachem Holding AG ranks #140 out of 1412 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bachem Holding AG has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's Return-on-Tangible-Asset compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bachem Holding AG ranks #140 out of 1412 companies for Return-on-Tangible-Asset. This places Bachem Holding AG in the top 10% of its industry — outperforming the majority of peers. Historically, Bachem Holding AG's own Return-on-Tangible-Asset has ranged from 6.74 to 11.73 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Biotechnology company?
A good Return-on-Tangible-Asset depends on the Biotechnology industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Bachem Holding AG and its competitors. Bachem Holding AG's current Return-on-Tangible-Asset is 10.04%, which is 22% above median its own 10-year median of 8.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (BCHMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $98.06, compared to a current price of $87.34 — trading 10.9% below its estimated fair value. The current Return-on-Tangible-Asset is 10.04%, which is 22% above median its 10-year median of 8.22. Bachem Holding AG's overall GF Score™ is 96/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Bachem Holding AG (BCHMF), the current Return-on-Tangible-Asset is 10.04% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bachem Holding AG (BCHMF) Overvalued in 2026?
Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued.
The current stock price of $87.34 is trading 10.9% below its estimated GF Value™ of $98.06.
GuruFocus considers Bachem Holding AG to be Modestly Undervalued.
Key valuation signals for BCHMF:
Return-on-Tangible-Asset: 10.04% (22% above median its 10-year median of 8.22)
GF Value™: $98.06 vs. price of $87.34 (10.9% below fair value)
No single metric tells the full story. See the BCHMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
96GF Score
Get the complete analysis for BCHMF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BCHMF has been successfully added to your 
